Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, USA.
Lab Chip. 2019 Feb 12;19(4):682-692. doi: 10.1039/c8lc01367e.
Streptococcus pneumoniae (pneumococcus), a deadly bacterial human pathogen, uses genetic transformation to gain antibiotic resistance. Genetic transformation begins when a pneumococcal strain in a transient specialized physiological state called competence, attacks and lyses another strain, releasing DNA, taking up fragments of the liberated DNA, and integrating divergent genes into its genome. While many steps of the process are known and generally understood, the precise mechanism of this natural genetic transformation is not fully understood and the current standard strategies to study it have limitations in specifically controlling and observing the process in detail. To overcome these limitations, we have developed a droplet microfluidic system for isolating individual episodes of bacterial transformation between two confined cells of pneumococcus. By encapsulating the cells in a 10 μm diameter aqueous droplet, we provide an improved experimental model of genetic transformation, as both participating cells can be identified, and the released DNA is spatially restricted near the attacking strain. Specifically, the bacterial cells, one rifampicin (R) resistant, the other novobiocin (N) and spectinomycin (S) resistant were encapsulated in droplets carried by the fluorinated oil FC-40 with 5% surfactant and allowed to carry out competence-specific attack and DNA uptake (and consequently gain antibiotic resistances) within the droplets. The droplets were then broken, and recombinants were recovered by selective plating with antibiotics. The new droplet system encapsulated 2 or more cells in a droplet with a probability up to 71%, supporting gene transfer rates comparable to standard mixtures of unconfined cells. Thus, confinement in droplets allows characterization of natural genetic transformation during a strictly defined interaction between two confined cells.
肺炎链球菌(肺炎球菌)是一种致命的人类病原菌,它利用遗传转化获得抗生素耐药性。遗传转化始于处于短暂特殊生理状态的肺炎球菌菌株(称为感受态)攻击和溶解另一个菌株,释放 DNA,摄取释放的 DNA 片段,并将不同的基因整合到其基因组中。虽然该过程的许多步骤是已知的,并且通常被理解,但这种自然遗传转化的确切机制尚未完全理解,目前研究它的标准策略在详细控制和观察该过程方面存在局限性。为了克服这些限制,我们开发了一种用于在两个受限肺炎球菌细胞之间隔离单个细菌转化事件的液滴微流控系统。通过将细胞封装在 10μm 直径的水相中,我们提供了一种改进的遗传转化实验模型,因为两个参与的细胞都可以被识别,并且释放的 DNA 被限制在攻击菌株附近的空间内。具体而言,将对利福平(R)、新生霉素(N)和壮观霉素(S)具有抗性的细菌细胞封装在含有 5%表面活性剂的氟化油 FC-40 携带的液滴中,允许它们在液滴内进行特定于感受态的攻击和 DNA摄取(并因此获得抗生素抗性)。然后将液滴打破,并通过选择性抗生素平板培养回收重组体。新的液滴系统以高达 71%的概率将 2 个或更多个细胞封装在一个液滴中,支持与未受限细胞的标准混合物相当的基因转移率。因此,在液滴中的限制允许在两个受限细胞之间的严格定义的相互作用期间对自然遗传转化进行表征。